Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Center of Mental Health,
Department of Child and Adolescent Psychiatry,
Psychosomatics and Psychotherapy,
Center of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy
Manfred Gerlach has not added Biography.
If you are Manfred Gerlach and would like to personalize this page please email our Author Liaison for assistance.
Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease.
Parkinsonism & related disorders , 2008 | Pubmed ID: 18585086
Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) Dec, 2011 | Pubmed ID: 21253782
Flibanserin attenuates L: -DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Journal of neural transmission (Vienna, Austria : 1996) Dec, 2011 | Pubmed ID: 21274579
Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics.
Journal of neural transmission (Vienna, Austria : 1996) Jan, 2012 | Pubmed ID: 21755462
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson's disease: differential role of α(2) adrenergic mechanisms.
Journal of neural transmission (Vienna, Austria : 1996) Jan, 2013 | Pubmed ID: 22592937
Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
Attention deficit and hyperactivity disorders Jun, 2013 | Pubmed ID: 23605387
Annual report 2015.
Attention deficit and hyperactivity disorders Mar, 2016 | Pubmed ID: 26895449
What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?
Attention deficit and hyperactivity disorders Mar, 2017 | Pubmed ID: 28168407
Editors must be vigilant to guarantee the quality and credibility of published scientific work.
Attention deficit and hyperactivity disorders Dec, 2018 | Pubmed ID: 30328576
Special edition on the occasion of Jan K. Buitelaar's 65th anniversary.
Attention deficit and hyperactivity disorders Mar, 2019 | Pubmed ID: 30758776
The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder.
Neuroscience and biobehavioral reviews 09, 2021 | Pubmed ID: 33549739
University Hospital of Wuerzburg, University of Wuerzburg
Maximilian Wulf1,2,
Katalin Barkovits-Boeddinghaus1,2,
Paula Sommer1,2,
Karin Schork1,2,
Martin Eisenacher1,2,
Peter Riederer3,4,
Manfred Gerlach5,
Steffen Kösters1,2,
Britta Eggers*,1,2,
Katrin Marcus*,1,2
1Medizinisches Proteom-Center, Medical Faculty, Ruhr-University Bochum,
2Medical Proteome Analysis, Center for Proteindiagnostics (PRODI), Ruhr-University Bochum,
3Center of Mental Health; Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University Hospital Wuerzburg,
4Psychiatry Department of Clinical Research, University of Southern Denmark Odense University Hospital,
5Center of Mental Health, Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital of Wuerzburg, University of Wuerzburg
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.